Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prion-like protein doppel (PRND) is a membrane glycosylphosphatidylinositol (GPI)-anchored glycoprotein with significant structural similarity to the cellular prion protein (PrPC), sharing about 25% sequence identity in key regions[1][3]. The PRND gene is located on chromosome 20 in humans, close to the prion protein gene (PRNP)[3][5]. Unlike PrPC, PRND (Doppel) is predominantly expressed in the testis and is required for normal acrosome function and male fertility, with much lower expression in the adult central nervous system[1][3][5]. It is not involved in the propagation of misfolded prion protein associated with transmissible spongiform encephalopathies, but its role in neurodegenerative disease remains under investigation, as animal studies have linked doppel overexpression in the brain to neurodegeneration[1][5]. Mutations in PRND may be associated with neurodegenerative disease risk, but evidence in humans is contradictory and does not establish a clear causal link[1][5]. No drugs are currently known to target PRND directly, and it is not considered a therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prion-like protein doppel (PRND).